Electrochemical telomerase assay for oral cancer screening

被引:0
作者
Tominaga, Kazuhiro [1 ]
Kodama, Masaaki [1 ]
Hayakawa, Mana [1 ]
Habu, Manabu [1 ]
Sato, Shinobu [2 ]
Takenaka, Shigeori [2 ]
机构
[1] Kyushu Dent Univ, Dept Oral & Maxillofacial Surg, Kitakyushu, Fukuoka, Japan
[2] Kyushu Inst Technol, Dept Appl Chem, Kitakyushu, Fukuoka, Japan
来源
2014 WORLD AUTOMATION CONGRESS (WAC): EMERGING TECHNOLOGIES FOR A NEW PARADIGM IN SYSTEM OF SYSTEMS ENGINEERING | 2014年
关键词
telomerase; oral cancer screening; electrochemical assay; CELL CARCINOMA PATIENTS; MARKER; LESIONS;
D O I
暂无
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Telomerase has long been known as a cancer marker. As an easy-to-perform oral cancer screening system, we established a new electrochemical telomerase assay (ECTA) method that is superior to a telomerase repeat amplification protocol assay, a popular method for detection of telomerase activity. In the present study, we employed 3 types of clinical samples to examine the sensitivity and specificity of ECTA. Three types of samples were obtained from 44 oral squamous cell carcinoma patients and 16 healthy volunteers; exfoliated cells from the whole oral cavity, exfoliated cells from local lesions, and tissue samples from lesions. Telomerase activity was determined in the samples using ECTA. The increase in current in the oral cancer group was significantly higher than that in the healthy volunteer group for each sample type, while there were no significant differences among the 3 sample types in the oral cancer group. The sensitivity and specificity of ECTA was 94.6% and 88.6%, respectively. Our novel ECTA method showed excellent detection of telomerase activity and is consider applicable as an oral cancer screening system.
引用
收藏
页数:5
相关论文
共 19 条
  • [1] Califano J, 1996, CANCER RES, V56, P5720
  • [2] Dejmek A, 2001, DIAGN CYTOPATHOL, V24, P11, DOI 10.1002/1097-0339(200101)24:1<11::AID-DC1001>3.0.CO
  • [3] 2-A
  • [4] Telomerase as tumor marker
    Hiyama, E
    Hiyama, K
    [J]. CANCER LETTERS, 2003, 194 (02) : 221 - 233
  • [5] Kavaler E, 1998, CANCER, V82, P708, DOI 10.1002/(SICI)1097-0142(19980215)82:4<708::AID-CNCR14>3.0.CO
  • [6] 2-1
  • [7] SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER
    KIM, NW
    PIATYSZEK, MA
    PROWSE, KR
    HARLEY, CB
    WEST, MD
    HO, PLC
    COVIELLO, GM
    WRIGHT, WE
    WEINRICH, SL
    SHAY, JW
    [J]. SCIENCE, 1994, 266 (5193) : 2011 - 2015
  • [8] ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor
    Kodama, T
    Ikeda, E
    Okada, A
    Ohtsuka, T
    Shimoda, M
    Shiomi, T
    Yoshida, K
    Nakada, M
    Ohuchi, E
    Okada, Y
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (05) : 1743 - 1753
  • [9] Oral Cancer Diagnosis via a Ferrocenylnaphthalene Diimide-Based Electrochemical Telomerase Assay
    Mori, Kumiko
    Sato, Shinobu
    Kodama, Masaaki
    Habu, Manabu
    Takahashi, Osamu
    Nishihara, Tatsuji
    Tominaga, Kazuhiro
    Takenaka, Shigeori
    [J]. CLINICAL CHEMISTRY, 2013, 59 (01) : 289 - 295
  • [10] Rajput Dinesh V, 2010, J Oral Maxillofac Pathol, V14, P52, DOI 10.4103/0973-029X.72501